On Oct. 2, 2020, LabCorp announced that it had received an Emergency Use Authorization (EUA) from the FDA for a new, high-throughput method that uses heat and technology to extract RNA from samples collected for COVID-19 molecular testing. The advancement will help the company improve the speed and efficiency of RT-PCR tests, considered the ﾑgold standardﾒ for active infections.